Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PRM

Perimeter Solutions Acquires Medical Manufacturing Technologies for $685M

Perimeter Solutions, Inc. has completed the acquisition of Medical Manufacturing Technologies LLC (MMT) from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits. The transaction was financed with cash on hand and the proceeds of the senior secured notes offering that closed on January 2, 2026.

MMT is a leading provider of highly engineered machinery and associated aftermarket consumables, parts, and services for the manufacturing of minimally invasive medical devices. Nearly all MMT’s revenue is generated from proprietary products, and about half of its revenue is derived from the aftermarket.

Perimeter Solutions is organized and managed in two reporting segments: Fire Safety and Specialty Products. The Fire Safety segment offers specialized equipment and services, including airbase retardant storage, mixing, and delivery equipment, mobile retardant bases, and mobile foam equipment. Its service network can meet the emergency resupply needs of approximately 150 air tanker bases in North America, as well as many other customer locations globally. The segment sells products to government agencies and commercial customers around the world.

The Specialty Products segment includes Phosphorus Derivatives, Inc. (PDI), which produces Phosphorus Pentasulfide (P2S5) based lubricant additives used in pesticide and mining chemicals applications, and emerging electric battery technologies. The segment also includes Intelligent Manufacturing Solutions (IMS), a manufacturer of electronic or electro-mechanical components of larger solutions with a substantial focus on aftermarket repair and replacement.

The completion of the acquisition and the financing with cash on hand and new secured notes offering are significant financial developments for Perimeter Solutions, reflecting the company's strategic expansion and investment in new markets and capabilities. The market has reacted to these announcements by moving the company's shares -2.42% to a price of $28.62. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS